Abstract: The disclosure relates to a nasal cannula comprising a port configured for delivery of a medicament into a flow of a fluid being delivered by the nasal cannula to a user and/or configured for interfacing with a medicament delivery device or an instrument. The disclosure also relates to a nasal cannula comprising an asymmetric profile to reduce an amount of occlusion of one nare of a user to provide access for an instrument to the nare with the nasal cannula in use.

Abstract: A respiratory humidification device includes: a casing; a separator wall to divide an interior space into filling and humidification chambers, wherein a bottom edge of the separator wall leaves a space between it and the casing bottom to define a passage allowing water to flow atop the casing bottom between the chambers, and enabling the water level to rise enough to block the passage to prevent respiratory gas from passing therethrough; a valve and float within the filling chamber to control water flow into the filling chamber to prevent the water level from rising higher than a threshold; and wherein an outer wall of the casing and the separator wall cooperate with the water surface within the humidification chamber to define an elongate tube-like pathway through which respiratory gas proceeds along a path extending generally parallel to the water surface within the humidification chamber to be humidified.

Abstract: An oral and nasal sealing interface pad including a rigid part and a lining pad. The rigid part has a circular opening on one side and a joint part on the other side; the lining pad is fixedly connected to the joint part and is located below the user's nose. The lining pad includes a nasal area corresponding to and abutting the user's nasal tip and a mouth area corresponding to and surrounding the user's mouth. The space enclosed by the nasal area is connected to the space enclosed by the mouth area, together forming an integrated respiratory chamber. The nasal area includes a nasal tip area and an alar area. The nasal tip area has at least one thin area for accommodating the user's nasal tip, and the nasal tip area is equipped with a first wing for abutting against the user's columella.

Abstract: A positive pressure ventilation apparatus may include a positive pressure mask; a positive pressure source; and an exhalation filter. The positive pressure mask may include a mask body having a patient-contact perimeter and including a flexible concertinaed portion of uniform flexion continuously around the mask body. The flexible concertinaed portion may include a plurality of ridges. The positive pressure mask may further include a gas inlet to the mask body configured to be connected to the positive-pressure source; and an adhesive seal positioned at the patient-contact perimeter which may be positioned at the outermost portion of the patient contact perimeter. The adhesive seal may comprise one or more lavers. Each layer may include one or more cover members, each of which may include at least one removable tab; and at least one perforation. Each layer may further include a dual-sided form carrier with adhesive material on one or both sides.

Abstract: Apparatus for treating a respiratory disorder in a patient comprises a pressure generator configured to deliver a flow of air at positive pressure to an airway of the patient through a patient interface, a sensor configured to generate a respiratory flow rate signal of the patient, and a controller. The controller may be configured to control the generator to deliver ventilation therapy having a base pressure and a pressure support through the patient interface, detect an apnea from the signal representative of respiratory flow rate of the patient, control the generator to deliver one or more probe breaths to the patient during the apnea, determine patency of the patient's airway from a waveform of the respiratory flow rate signal in response to one of the one or more probe breaths and adjust a set point for pressure of the ventilation therapy in response to the apnea.

Abstract: Various control methods can indirectly determine incorrect connections between components in a respiratory therapy system. For example, errors in the connections can occur between a patient interface, a humidifier and/or a gases source. The methods can indirectly detect if a reverse flow condition exists or other error conditions. A reverse flow condition can occur when gases flows in a direction different from an intended direction of flow. The detection of the reverse flow condition can be indicative of likely errors in connections between the humidifier, patient interface and/or gases source.

Abstract: The invention relates to a device (10) for selective regionalization of pulmonary aeration, intended to apply a vacuum over a posterolateral part of a patient's chest wall, said device comprising a rigid or semi-rigid shell (11) intended to selectively surround a posterior part of the patient's chest wall, and a layer of honeycomb material (12) covering an internal wall (13) of the rigid shell, intended to be in contact with the patient's chest wall, said shell comprising at least one through hole (14), intended to be connected to a negative pressure generator.

Abstract: A T-piece for ventilating a neonate includes a body having three ports, including an air supply connection port configured to connect to an air supply hose to receive gas therefrom, a mask connection port configured to connect to a neonatal ventilation mask, and a positive end-expiratory pressure (PEEP) control port. A PEEP adjustor cap is connected to the PEEP control port, the PEEP adjustor cap having a bypass hole to allow gas to exit the T-piece and configured such that when the bypass hole is closed substantially all gas received at the air supply connection port is directed to the neonate, and when the bypass hole is open at least a portion of the gas received at the air supply connection port exits through the bypass hole. The T-piece is configured such that the bypass hole can be closed to deliver a sustained breath procedure to a neonate. A sustained breath delivery timer configured to limit a duration of the sustained breath procedure.

Abstract: High flow therapy is used to treat Cheyne-Stokes respiration and other types of periodic respiration disorders by periodic application of high flow therapy, adjustment of high flow therapy flow rates and/or periodic additions of CO2 or O2 into the air flow provided to the patient.

Abstract: An airway management device comprising a body having a proximal end for receiving an oxygen supply tube and an distal end for insertion into a trachea of a patient; said body including a linear portion adjacent to the proximal end and a curved portion adjacent to the distal end; said body including an external shell and having a first bore through said shell for receiving the oxygen supply tube; wherein flexural strength for said airway management device is provided by said shell.

Abstract: An apparatus or kit for a respiratory support system for delivering humidified gas to a user or patient. The apparatus comprising a humidifier chamber in pneumatic communication with a gases source, an inspiratory conduit in pneumatic communication with the humidifier chamber downstream of the humidifier chamber, a filter that is in pneumatic communication with the inspiratory conduit downstream of the inspiratory conduit, and a patient interface for delivering humidified gas to a user or patient, wherein the patient interface is in pneumatic communication with the filter downstream of the filter, or is configured to be placed in pneumatic communication with the filter downstream of the filter.

Abstract: An apparatus for oxygenation and/or CO2 clearance of a patient. The apparatus comprising: a flow source or a connection for a flow source for providing a gas flow, a gas flow modulator, a controller to control the gas flow. The controller is operable to: receive input relating to heart activity and/or trachea gas flow of the patient, and control the gas flow modulator to provide a varying gas flow with at least two oscillating components. One oscillating component has a frequency based on the heart activity and/or trachea flow of the patient. One oscillating component has a frequency to: promote bulk gas flow movement, or promote mixing.

Abstract: The invention relates to the field of inhalation devices for liquids. In particular, the invention relates to a nebulizing nozzle to be used in such an inhalation device, as well as a method for fabrication of such a nozzle. A nozzle for an inhalation device for nebulizing a liquid into a respirable aerosol has a nozzle body (1) which has a front end (1B) and which comprises at least two ejection channels (2, 2?), each channel (2, 2?) having an channel exit (2A, 2A?), wherein the ejection channels (2, 2?) are arranged such as to eject liquid along respective ejection trajectories which intersect with one another at a collision point. The nozzle is characterized in that at least one recess (3) is provided at the front end (1B) in which the channel exits (2A, 2A?) are positioned.

Abstract: The present disclosure describes a system that automatically detects patient-ventilator asynchrony and trends in patient-ventilator asynchrony. The present disclosure describes a framework that uses pressure, flow, and volume waveforms to detect patient-ventilator asynchrony and the presence of secretions in the ventilator circuit.

Abstract: A water reservoir for an apparatus for humidifying a flow of breathable gas includes a reservoir body forming a cavity structured to hold a volume of liquid. The reservoir body comprises a conductive portion. The conductive portion comprises a thermally conductive material and is adapted to thermally engage with a heater plate to allow thermal transfer of heat to the liquid. The conductive portion includes a peripheral interfacing portion structured and arranged to connect the conductive portion to one or more walls of the reservoir body. The peripheral interfacing portion includes an intermediate portion and an end portion. The end portion is bent so as to be at least inclined with respect to the intermediate portion to reduce a risk of leakage caused by cracks within a critical area of a thickness of the one or more walls due to a presence of a sharp edge at the end portion.

Abstract: The invention is a method for stimulating tracheobronchial air of a patient suffering from an obstructive ventilatory disorder and modifying a rheology of the patient's tracheobronchial mucus. The method includes: interfacing a respiratory system of the patient with a physiological interface connected to a negative pressure generator with a connecting pipe; applying alternations of negative pressure with the negative pressure generator and venting impulses with a first determined frequency and duty cycle during a first part of an expiration cycle; applying a succession of alternations of negative pressure with the negative pressure generator and venting impulses with a second determined frequency and a second determined duty cycle during a second part of said expiration cycle; a duty cycle corresponding to a ratio between the duration during which a negative pressure is applied and the total duration of an expiration cycle; and reiterating a defined number of expiration cycles.

Abstract: Systems and methods are disclosed for categorizing and/or characterizing a user interface. The systems and methods include generating acoustic data associated with an acoustic reflection of an acoustic signal, the acoustic reflection being indicative of, at least in part, one or more features of a user interface coupled to a respiratory therapy device via a conduit. The systems and methods further include analyzing the generated acoustic data. The systems and methods further include categorizing and/or characterizing the user interface based, at least in part, on the analyzed acoustic data.

Abstract: A patient interface may include a plenum chamber pressurisable to a therapeutic pressure, a seal-forming structure constructed and arranged to form a seal with a region of the patient's face surrounding an entrance to the patient's airways, a positioning and stabilising structure to provide a force to hold the seal-forming structure in a therapeutically effective position on the patient's head, and a vent structure to allow a continuous flow of gases exhaled by the patient from an interior of the plenum chamber to ambient, wherein the patient interface is configured to leave the patient's mouth uncovered during therapy, wherein the seal-forming structure comprises two lateral support regions, each located at a lateralmost side of the seal-forming structure, and a medial region positioned between the lateral support regions, the hole passing through the medial region, and wherein the lateral support regions are thicker than the medial region.

Abstract: A respiratory conduit apparatus that conducts a breathable gas for respiratory therapy may include electrical circuit components to assist with therapy. In an example, a delivery conduit for connection with a patient interface and a respiratory therapy device may include a cuff having a microcontroller unit. The cuff may be configured with circuit components for accessory identification, gas characteristic detection for therapy control, heating and communications. In some versions, the delivery conduit may include a controller in a circuit board assembly located at an end of the delivery conduit. The printed circuit board may be configured to control and power the components of the cuff, as well as communicate with a respiratory therapy device.

Abstract: Ventilator system with multiple inspiratory lumens is provided. The inspiratory lumens are configured so that separate inspiratory lumens provide inspiratory gas mixtures to separate portions of a patient's airways, for instance to separate lungs and/or bronchi. The ventilator system can include one or more expiratory lumens to evacuate expiratory gases from airways. The use of separate inspiratory lumen(s), with expiratory lumen(s), allows for functional separation of structural portions of the lungs, and maintenance of continuous or almost continuous flow through at least part of respiratory cycle via inspiratory and expiratory lumens. This can further reduce dead space and clear suspended therein diseases causative agents with improvement in outcomes, reduce risk of cross-contamination or cross-infection between different parts of airways, for example such as cross-infection from one lung lobe to another lobe or.